2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Insurance Revenue | -- | -- | -- | -- | -- | -- |
Interest Income | -- | -- | -- | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | 59,900,000 | 7.467% | 55,738,000 | 101,759,000 | 92,569,000 | 87,907,000 |
Net Premium Income | 57,726,000 | 7.917% | 53,491,000 | 97,282,000 | 90,777,000 | 82,003,000 |
Investment Income/(Loss) | 15,242,000 | -18.409% | 18,681,000 | 14,086,000 | 13,483,000 | 12,370,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | 5,826,000 | 4,639,000 | 872,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | (2,816,000) | 930,000 | (483,000) |
Other Income/(Loss) | 3,298,000 | 16.250% | 2,837,000 | 3,272,000 | 2,987,000 | 3,621,000 |
Total Revenues | 76,266,000 | 1.676% | 75,009,000 | 117,650,000 | 112,816,000 | 98,383,000 |
Insurance Service Expenses | -- | -- | -- | -- | -- | -- |
Net Expenses from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (70,276,000) | -0.342% | (70,517,000) | (114,244,000) | (108,641,000) | (95,753,000) |
Other Non-operating Items | -- | -- | -- | 0 | 0 | 0 |
Share of results of Associates & JCEs | (216,000) | -- | 313,000 | 2,319,000 | 2,243,000 | 2,454,000 |
Profit / (Loss) before Taxation | 5,774,000 | 20.166% | 4,805,000 | 5,725,000 | 6,418,000 | 5,084,000 |
Taxation | (1,908,000) | 977.966% | (177,000) | 295,000 | (737,000) | 67,000 |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (128,000) | -4.478% | (134,000) | (137,000) | (62,000) | (65,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 3,738,000 | -16.822% | 4,494,000 | 5,883,000 | 5,619,000 | 5,086,000 |
2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Depreciation & Amortisation | 1,649,000 | -0.722% | 1,661,000 | 1,715,000 | 1,376,000 | 1,357,000 |
Directors' Emoluments | 21,816 | -7.051% | 23,471 | 22,260 | 19,207 | 18,655 |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 32.000 | -25.581% | 43.000 | 57.000 | 54.000 | 49.000 |
DPS (cts) | 18.000 | -- | 18.000 | -- | -- | -- |
Dividend Payout Ratio (%) | 56.250% | -- | 41.860% | -- | -- | -- |
Cash flow per share ($) | 1.768 | -- | 2.487 | 4.306 | 3.784 | 2.688 |
NBV per share ($) | 5.255 | -- | 5.049 | -- | -- | -- |
Remarks: | Real time quote last updated: 23/08/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,738,000 |
%Change | -16.822% |
EPS / (LPS) | RMB 0.320 |
NBV Per Share (¥) | RMB 5.255 |